Literature DB >> 27598996

High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.

Xiaojia Huang1, Xing Li1, Xinhua Xie1, Feng Ye1, Bo Chen1, Cailu Song1, Hailin Tang2, Xiaoming Xie3.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the potential correlation between lactate dehydrogenase A (LDHA) and AMP-activated protein kinase (AMPK) and their clinicopathologic significance in breast cancer.
MATERIALS AND METHODS: Western blot and qRT-PCR were used to detect the expression levels of LDHA and AMPK in eight breast cancer lines and eight breast cancer tissues. In addition, LDHA and AMPK were detected by immunohistochemistry (IHC) using breast cancer tissue microarrays (TMAs) of 112 patients. The association between LDHA and AMPK expression levels was statistically analyzed. So were the prognostic roles and clinicopathologic significances in breast cancer.
RESULTS: The expression levels of LDHA and AMPK were relatively higher in triple-negative breast cancer (TNBC) cell lines than in non-triple-negative breast cancer (NTNBC) cell lines. LDHA and AMPK were also further up-regulated in TNBC tissues than in NTNBC tissues. Correlation analysis showed a positive correlation between LDHA and AMPK expression levels. Expression of LDHA and AMPK were significantly correlated with TNM stage, distant metastasis, Ki67 status and survival outcomes of patients. Patients with both positive expression of LDHA and AMPK showed shorter overall survival (OS) and disease-free survival (DFS).
CONCLUSIONS: These findings improve our understanding of the expression pattern of LDHA and AMPK in breast cancer and clarify the role of LDHA and AMPK as promising prognostic biomarkers for breast cancer.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  AMPK; Breast cancer; LDHA; Prognosis; Tumor metabolism

Mesh:

Substances:

Year:  2016        PMID: 27598996     DOI: 10.1016/j.breast.2016.08.014

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  40 in total

Review 1.  Emerging roles of aerobic glycolysis in breast cancer.

Authors:  Z Wu; J Wu; Q Zhao; S Fu; J Jin
Journal:  Clin Transl Oncol       Date:  2019-07-29       Impact factor: 3.405

Review 2.  Lactate metabolism: historical context, prior misinterpretations, and current understanding.

Authors:  Brian S Ferguson; Matthew J Rogatzki; Matthew L Goodwin; Daniel A Kane; Zachary Rightmire; L Bruce Gladden
Journal:  Eur J Appl Physiol       Date:  2018-01-10       Impact factor: 3.078

3.  AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.

Authors:  Ruchi Roy; Eun-Ryeong Hahm; Alexander G White; Carolyn J Anderson; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2019-03-05       Impact factor: 4.784

4.  A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients.

Authors:  Xiaofeng Wu; Jing Zhu; Wei Liu; Meng Jin; Mengqing Xiong; Ke Hu
Journal:  Int J Gen Med       Date:  2021-12-30

Review 5.  Glycolysis in the progression of pancreatic cancer.

Authors:  Xinyao Chang; Xingchen Liu; Haoze Wang; Xuan Yang; Yan Gu
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

6.  Circ-DONSON Facilitates the Malignant Progression of Gastric Cancer Depending on the Regulation of miR-149-5p/LDHA Axis.

Authors:  Yingying Shao; Fangshun Li; Hanlin Liu
Journal:  Biochem Genet       Date:  2021-08-18       Impact factor: 1.890

7.  MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.

Authors:  Hanwen Chen; Shuming Gao; Cai Cheng
Journal:  Hum Cell       Date:  2018-08-07       Impact factor: 4.174

Review 8.  Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing.

Authors:  Vinod S Bisht; Kuldeep Giri; Deepak Kumar; Kiran Ambatipudi
Journal:  Cancer Biol Ther       Date:  2021-10-25       Impact factor: 4.742

9.  Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer.

Authors:  Jonathan M Ghergurovich; Jessica D Lang; Maren K Levin; Natalia Briones; Salvatore J Facista; Claudius Mueller; Alexis J Cowan; Matthew J McBride; Esther San Roman Rodriguez; Aaron Killian; Tuoc Dao; Jeffrey Lamont; Alison Barron; Xiaoyang Su; William P D Hendricks; Virginia Espina; Daniel D Von Hoff; Joyce O'Shaughnessy; Joshua D Rabinowitz
Journal:  Med (N Y)       Date:  2021-04-14

10.  Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.

Authors:  Aoshuang Qi; Mingyi Ju; Yinfeng Liu; Jia Bi; Qian Wei; Miao He; Minjie Wei; Lin Zhao
Journal:  Pathol Oncol Res       Date:  2021-04-01       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.